The Proteinase K Market, estimated at USD 31.5 Mn in 2025, is expected to exhibit a CAGR of 6.2% and reach USD 48.0 Mn by 2032.
The market growth is fueled by rising demand for advanced biotechnology solutions that improve healthcare outcomes, along with increasing adoption in areas such as drug development, diagnostics, and personalized medicine. Innovations in genomics, cell and gene therapies, and biomanufacturing, supported by strong R&D investments, are enhancing treatment effectiveness, efficiency, and accessibility. Furthermore, favorable regulatory support, strategic collaborations, and the growing focus on precision medicine are accelerating market expansion and opening new opportunities for industry participants.
The increasing initiatives of the government by providing research funding is expected to provide lucrative growth opportunities for players. For example, in September, 2025, The White House, announced federal funding of more than US$ 2 billion to advance President Joe Biden's executive order intended to enable the U.S. to harness the full potential of biotechnology and biomanufacturing. Such initiatives by the government will boost the research in biotechnology field and hence will show positive impact on Global Proteinase K market.
Global Proteinase K market – Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2025 as "coronavirus disease 2025" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems with regard to the transportation of drugs from one place to another.
COVID-19 had a positive impact on the global proteinase K market. The COVID-19 pandemic boosted the demand for proteinase K, exponentially propelling the growth of the market. Proteinase K is widely employed in extraction protocols of genetic material. It is important since it can absorb proteins that eliminate cross-contamination from nucleic acids. According to a study published on Public Library of Science one (PLOS one), in March 2025, proteinase K treatment, followed by thermal shock for RNA extraction of COVID-19, is a faster and relatively cost-effective alternative as compared to commercial kits. The study was conducted by the National Institute of Health, Lima, Peru where they compared the COVID-19 positivity between six epidemiological weeks. For first two weeks, the Real time Reverse Transcription – Polymerase Chain Reaction (RT-PCR) was conducted using RNA extracted by commercial kit, followed by two other using RNA obtained by NIH’s test kit-free method, and the last two using NIH’s test kit once again. As per the results, it was concluded that NIH’s method was an easy, fast, and cost-effective alternative method for extracting RNA and conducting molecular diagnosis of COVID-19.
Global Proteinase K Market: Key Developments
On December 8, 2025, Thermo Fisher Scientific In, a U.S.-based supplier of scientific instrumentation, reagents and consumables, and software services, announced that it has completed its acquisition of Pharmaceutical Product Development, Inc., U.S. based provider of clinical research services to the biopharma and biotech industry, for US$ 17.4 billion. With the takeover, Thermo Fisher intends to provide a complete suite of services across the clinical development spectrum, comprising scientific discovery, safety, efficacy, and healthcare outcome assessment, handling trial logistics, as well as the development and production of the therapeutics. This will drive the growth of the clinical research service industry hence the demand for Proteinase K will also increase as it is a widely used reagent in clinical research.